Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
1.
J Environ Radioact ; 274: 107411, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38471302

RESUMEN

Consumption of local and imported bottled water in Canada has greatly increased during the past three decades. While the presence of natural radioactivity is often overlooked when dealing with the water quality of these bottled products, it could contribute substantially to the uptake of radionuclides especially when sourced from regions with higher radioactivity levels compared to where it is consumed. In this study, the activity of several naturally occurring radionuclides (i.e., 210Po, 226,228Ra, 230,232Th, 234,235,238U) were measured in bottled water available in Québec, Canada after sample pretreatment and analysis by either radiometric or mass spectrometry approaches. 230,232Th and 228Ra concentrations were below minimum detectable activity levels in all samples tested. Analytical results for 234U, 235U, 238U, and 226Ra showed concentrations that ranged from 0.38 to 115 mBq/L, (2.2-313) x 10-2 mBq/L, 0.48-58.4 mBq/L, and 1.1-550 mBq/L, respectively. 210Po was detected in only 5 samples and its activity ranged from 2 to 26 mBq/L. To determine variability in activity within brands, the same brands of bottled water were purchased during two consecutive years and analyzed. The possible radiological impact of the consumption of these types of water was assessed based on different drinking habit scenarios. Some of the imported water brands showed higher activity concentrations than local sources or tap water, suggesting that individuals drinking predominantly imported bottled water would receive a higher radiation dose than those who drink mainly local water.


Asunto(s)
Agua Potable , Monitoreo de Radiación , Contaminantes Radiactivos del Agua , Humanos , Agua Potable/análisis , Quebec , Contaminantes Radiactivos del Agua/análisis , Monitoreo de Radiación/métodos , Radioisótopos/análisis , Canadá
2.
Proc Natl Acad Sci U S A ; 120(29): e2102408120, 2023 07 18.
Artículo en Inglés | MEDLINE | ID: mdl-37428929

RESUMEN

Although climate change has been implicated as a major catalyst of diversification, its effects are thought to be inconsistent and much less pervasive than localized climate or the accumulation of species with time. Focused analyses of highly speciose clades are needed in order to disentangle the consequences of climate change, geography, and time. Here, we show that global cooling shapes the biodiversity of terrestrial orchids. Using a phylogeny of 1,475 species of Orchidoideae, the largest terrestrial orchid subfamily, we find that speciation rate is dependent on historic global cooling, not time, tropical distributions, elevation, variation in chromosome number, or other types of historic climate change. Relative to the gradual accumulation of species with time, models specifying speciation driven by historic global cooling are over 700 times more likely. Evidence ratios estimated for 212 other plant and animal groups reveal that terrestrial orchids represent one of the best-supported cases of temperature-spurred speciation yet reported. Employing >2.5 million georeferenced records, we find that global cooling drove contemporaneous diversification in each of the seven major orchid bioregions of the Earth. With current emphasis on understanding and predicting the immediate impacts of global warming, our study provides a clear case study of the long-term impacts of global climate change on biodiversity.


Asunto(s)
Biodiversidad , Frío , Animales , Filogenia , Temperatura , Geografía , Especiación Genética
3.
Cells ; 10(11)2021 11 20.
Artículo en Inglés | MEDLINE | ID: mdl-34831473

RESUMEN

Anti-inflammatory low-dose therapy is well established, whereas the immunomodulatory impact of doses below 0.1 Gy is much less clear. In this study, we investigated dose, dose rate and time-dependent effects in a dose range of 0.005 to 2 Gy on immune parameters after whole body irradiation (IR) using a pro-inflammatory (ApoE-/-) and a wild type mouse model. Long-term effects on spleen function (proliferation, monocyte expression) were analyzed 3 months, and short-term effects on immune plasma parameters (IL6, IL10, IL12p70, KC, MCP1, INFγ, TGFß, fibrinogen, sICAM, sVCAM, sE-selectin/CD62) were analyzed 1, 7 and 28 days after Co60 γ-irradiation (IR) at low dose rate (LDR, 0.001 Gy/day) and at high dose rate (HDR). In vitro measurements of murine monocyte (WEHI-274.1) adhesion and cytokine release (KC, MCP1, IL6, TGFß) after low-dose IR (150 kV X-ray unit) of murine endothelial cell (EC) lines (H5V, mlEND1, bEND3) supplement the data. RT-PCR revealed significant reduction of Ki67 and CD68 expression in the spleen of ApoE-/- mice after 0.025 to 2 Gy exposure at HDR, but only after 2 Gy at LDR. Plasma levels in wild type mice, showed non-linear time-dependent induction of proinflammatory cytokines and reduction of TGFß at doses as low as 0.005 Gy at both dose rates, whereas sICAM and fibrinogen levels changed in a dose rate-specific manner. In ApoE-/- mice, levels of sICAM increased and fibrinogen decreased at both dose rates, whereas TGFß increased mainly at HDR. Non-irradiated plasma samples revealed significant age-related enhancement of cytokines and adhesion molecules except for sICAM. In vitro data indicate that endothelial cells may contribute to systemic IR effects and confirm changes of adhesion properties suggested by altered sICAM plasma levels. The differential immunomodulatory effects shown here provide insights in inflammatory changes occurring at doses far below standard anti-inflammatory therapy and are of particular importance after diagnostic and chronic environmental exposures.


Asunto(s)
Apolipoproteínas E/deficiencia , Inflamación/patología , Radiación Ionizante , Envejecimiento/sangre , Animales , Adhesión Celular/efectos de la radiación , Línea Celular , Citocinas/metabolismo , Relación Dosis-Respuesta en la Radiación , Células Endoteliales/efectos de la radiación , Femenino , Inflamación/sangre , Interleucina-6/metabolismo , Ratones Endogámicos C57BL , Monocitos/efectos de la radiación , Bazo/efectos de la radiación , Factores de Tiempo
4.
Nat Commun ; 12(1): 6092, 2021 10 19.
Artículo en Inglés | MEDLINE | ID: mdl-34667151

RESUMEN

Mutational hotspots can determine evolutionary outcomes and make evolution repeatable. Hotspots are products of multiple evolutionary forces including mutation rate heterogeneity, but this variable is often hard to identify. In this work, we reveal that a near-deterministic genetic hotspot can be built and broken by a handful of silent mutations. We observe this when studying homologous immotile variants of the bacteria Pseudomonas fluorescens, AR2 and Pf0-2x. AR2 resurrects motility through highly repeatable de novo mutation of the same nucleotide in >95% lines in minimal media (ntrB A289C). Pf0-2x, however, evolves via a number of mutations meaning the two strains diverge significantly during adaptation. We determine that this evolutionary disparity is owed to just 6 synonymous variations within the ntrB locus, which we demonstrate by swapping the sites and observing that we are able to both break (>95% to 0%) and build (0% to 80%) a deterministic mutational hotspot. Our work reveals a key role for silent genetic variation in determining adaptive outcomes.


Asunto(s)
Evolución Molecular , Pseudomonas fluorescens/genética , Mutación Silenciosa , Adaptación Fisiológica , Proteínas Bacterianas/genética , Análisis Mutacional de ADN , Pseudomonas fluorescens/fisiología
5.
Chem Biol Interact ; 341: 109464, 2021 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-33823170

RESUMEN

Current regulatory cancer risk assessment principles and practices assume a linear dose-response relationship-the linear no-threshold (LNT) model-that theoretically estimates cancer risks occurring following low doses of carcinogens by linearly extrapolating downward from experimentally determined risks at high doses. The two-year rodent bioassays serve as experimental vehicles to determine the high-dose cancer risks in animals and then to predict, by extrapolation, the number of carcinogen-induced tumors (tumor incidence) that will arise during the lifespans of humans who are exposed to environmental carcinogens at doses typically orders of magnitude below those applied in the rodent assays. An integrated toxicological analysis is conducted herein to reconsider an alternative and once-promising approach, tumor latency, for estimating carcinogen-induced cancer risks at low doses. Tumor latency measures time-to-tumor following exposure to a carcinogen, instead of tumor incidence. Evidence for and against the concept of carcinogen-induced tumor latency is presented, discussed, and then examined with respect to its relationship to dose, dose rates, and the dose-related concepts of initiation, tumor promotion, tumor regression, tumor incidence, and hormesis. Considerable experimental evidence indicates: (1) tumor latency (time-to-tumor) is inversely related to the dose of carcinogens and (2) lower doses of carcinogens display quantifiably discrete latency thresholds below which the promotion and, consequently, the progression and growth of tumors are delayed or prevented during a normal lifespan. Besides reconciling well with the concept of tumor promotion, such latency thresholds also reconcile favorably with the existence of thresholds for tumor incidence, the stochastic processes of tumor initiation, and the compensatory repair mechanisms of hormesis. Most importantly, this analysis and the arguments presented herein provide sound theoretical, experimental, and mechanistic rationales for rethinking the foundational premises of low-dose linearity and updating the current practices of cancer risk assessment to include the concept of carcinogen thresholds.


Asunto(s)
Pruebas de Carcinogenicidad/métodos , Carcinógenos/administración & dosificación , Carcinógenos/toxicidad , Neoplasias/inducido químicamente , Animales , Relación Dosis-Respuesta a Droga , Hormesis , Humanos , Incidencia , Neoplasias/epidemiología , Medición de Riesgo/métodos , Pruebas de Toxicidad Crónica/métodos
6.
Radiat Res ; 195(2): 211-217, 2021 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-33400791

RESUMEN

Cells exposed to fast neutrons often exhibit a non-Poisson distribution of chromosome aberrations due to the high ionization density of the secondary reaction products. However, it is unknown whether lymphocytes exposed to californium-252 (252Cf) spectrum neutrons, of mean energy 2.1 MeV, demonstrate this same dispersion effect at low doses. Furthermore, there is no consensus regarding the relative biological effectiveness (RBE) of 252Cf neutrons. Dicentric and ring chromosome formations were assessed in human peripheral blood lymphocytes irradiated at doses of 12-135 mGy. The number of aberrations observed were tested for adherence to a Poisson distribution and the maximum low-dose relative biological effectiveness (RBEM) was also assessed. When 252Cf-irradiated lymphocytes were examined along with previously published cesium-137 (137Cs) data, RBEM values of 15.0 ± 2.2 and 25.7 ± 3.8 were found for the neutron-plus-photon and neutron-only dose components, respectively. Four of the five dose points were found to exhibit the expected, or close to the expected non-Poisson over-dispersion of aberrations. Thus, even at low doses of 252Cf fast neutrons, when sufficient lymphocyte nuclei are scored, chromosome aberration clustering can be observed.


Asunto(s)
Aberraciones Cromosómicas/efectos de la radiación , Linfocitos/efectos de la radiación , Californio/farmacología , Radioisótopos de Cesio/farmacología , Relación Dosis-Respuesta en la Radiación , Neutrones Rápidos/efectos adversos , Rayos gamma/efectos adversos , Humanos , Linfocitos/patología , Efectividad Biológica Relativa
7.
Radiat Res ; 2020 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-33264403

RESUMEN

Cells exposed to fast neutrons often exhibit a non-Poisson distribution of chromosome aberrations due to the high ionization density of the secondary reaction products. However, it is unknown whether lymphocytes exposed to californium-252 (252Cf) spectrum neutrons, of mean energy 2.1 MeV, demonstrate this same dispersion effect at low doses. Furthermore, there is no consensus regarding the relative biological effectiveness (RBE) of 252Cf neutrons. Dicentric and ring chromosome formation was assessed in human peripheral blood lymphocytes irradiated at doses of 12-135 mGy. The number of aberrations observed were tested for adherence to a Poisson distribution and the maximum low-dose relative biological effectiveness (RBEM) was also assessed. When 252Cf-irradiated lymphocytes were examined along with previously published cesium-137 (137Cs) data, RBEM values of 15.0 ± 2.2 and 25.7 ± 3.8 were found for the neutron-plus-photon and neutron-only dose components, respectively. Four of the five dose points were found to exhibit the expected, or close to the expected non-Poisson over-dispersion of aberrations. Thus, even at low doses of 252Cf fast neutrons, when enough lymphocyte nuclei are scored, chromosome aberration clustering can be observed.

8.
PLoS One ; 15(4): e0232597, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32353063

RESUMEN

The use of low doses of radium-224 (224Ra) chloride for the treatment of ankylosing spondylitis was stopped following the discovery that patients treated with it had a higher than control incidence of leukaemia and other cancers. This was so even though the treatment resulted in decreased pain and increased mobility-both of which are associated with decreased mortality. It was decided to re-analyze the epidemiological data looking at all causes of death. The risk of leukaemia, solid cancer, death from non-cancer causes and from all causes in a study populations of men that received either the typical dose of 5.6 to 11.1 MBq of 224Ra, any dose of 224Ra or no radium were compared using the Cox proportional hazard model. For patients that received the typical dose of 224Ra agreed with the excess cancer was similar to that reported in previous studies. In contrast, these patients were less likely to die from non-cancer diseases and from all causes of death than the control patients. No excess mortality was also found in the population of all males that received the radionuclide. It is concluded that 224Ra treatment administered at low doses to patients with ankylosing spondylitis did not impact mortality from all causes. The study demonstrates the need to consider all causes of death and longevity when assessing health impacts following irradiation.


Asunto(s)
Causas de Muerte , Leucemia/mortalidad , Neoplasias Inducidas por Radiación/mortalidad , Radio (Elemento)/administración & dosificación , Retirada de Medicamento por Seguridad , Espondilitis Anquilosante/radioterapia , Torio/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Relación Dosis-Respuesta en la Radiación , Estudios de Seguimiento , Humanos , Inyecciones Intravenosas , Leucemia/etiología , Masculino , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/etiología , Dosificación Radioterapéutica , Radio (Elemento)/efectos adversos , Espondilitis Anquilosante/mortalidad , Torio/efectos adversos , Factores de Tiempo
9.
Sci Rep ; 9(1): 19919, 2019 12 27.
Artículo en Inglés | MEDLINE | ID: mdl-31882739

RESUMEN

The increased potential for tritium releases from either nuclear reactors or from new facilities raises questions about the appropriateness of the current ICRP and WHO recommendations for tritium exposures to human populations. To study the potential toxicity of tritium as a function of dose, including at a regulatory level, mice were chronically exposed to tritium in drinking water at one of three concentrations, 10 kBq.l-1, 1 MBq.l-1 or 20 MBq.l-1. Tritium was administered as either HTO or as tritiated non-essential amino acids (TAA). After one month's exposure, a dose-dependent decrease in red blood cells (RBC) and iron deprivation was seen in all TAA exposed groups, but not in the HTO exposed groups. After eight months of exposure this RBC decrease was compensated by an increase in mean globular volume - suggesting the occurrence of an iron deficit-associated anemia. The analysis of hematopoiesis, of red blood cell retention in the spleen and of iron metabolism in the liver, the kidneys and the intestine suggested that the iron deficit was due to a decrease in iron absorption from the intestine. In contrast, mice exposed to external gamma irradiation at equivalent dose rates did not show any change in red blood cell numbers, white blood cell numbers or in the plasma iron concentration. These results showed that health effects only appeared following chronic exposure to concentrations of tritium above regulatory levels and the effects seen were dependent upon the speciation of tritium.


Asunto(s)
Aminoácidos/química , Aminoácidos/farmacología , Hematopoyesis/efectos de los fármacos , Hierro/metabolismo , Tritio/química , Animales , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Agua Potable/efectos adversos , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Rayos gamma , Intestinos/citología , Hígado/citología , Masculino , Ratones , Ratones Endogámicos C57BL
10.
Int J Radiat Biol ; 95(10): 1361-1371, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-30582711

RESUMEN

Health risks associated with the exposure of humans to low-dose ionizing radiation are currently estimated using the Linear-No-Threshold model. Over the last few decades, however, this model has been widely criticized for inconsistency with a large body of experimental evidence. Substantial efforts have been made to delineate biological mechanisms and health-related outcomes of low-dose radiation. These include a large DOE-funded Low Dose program operated in the 2000s, as well as the EU funded programs, previously NOTE and DOREMI and currently MELODI. Although not as widely known, the Atomic Energy of Canada Limited (AECL) in Chalk River, operated a low-dose radiobiology program since as early as 1948. The Canadian Nuclear Laboratories (CNL), the successor to AECL since 2015, has expanded this program into new areas making it the world's most robust, centrally coordinated and long-lived research efforts to delineate the biological effects of low-dose radiation. The purpose of this review is to provide a high-level overview of the low-dose radiobiology program maintained at CNL while capturing the historical perspectives. Past studies carried out at CNL have substantially influenced the area of low-dose radiobiology, exemplified by highly cited papers showing delays in spontaneous tumorigenesis in low-dose irradiated mice. The current low-dose research program at CNL is not only addressing a wide range of mechanistic questions about the biological effects of low doses - from genetic to epigenetic to immunological questions - but also moving toward novel areas, such as the dosimetry and health consequences of space radiation and the use of low-dose radiation in cancer therapy and regenerative medicine.


Asunto(s)
Energía Nuclear , Radiobiología/tendencias , Investigación/tendencias , Algoritmos , Animales , Canadá , Reparación del ADN , Modelos Animales de Enfermedad , Humanos , Sistema Inmunológico , Cooperación Internacional , Modelos Lineales , Ratones , Mitocondrias/efectos de la radiación , Neoplasias/radioterapia , Neoplasias Inducidas por Radiación/epidemiología , Neoplasias Inducidas por Radiación/prevención & control , Neutrones , Radiometría , Especies Reactivas de Oxígeno , Células Madre
11.
Dose Response ; 17(4): 1559325819893195, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31903068

RESUMEN

This commentary highlights the published data on the metabolic processes that lead to the development of cancer following intakes of asbestos and chemical agents. Following exposure to both, the key initiating event is cell injury leading to cell death that may further lead to inflammation, fibrosis, and cancer. Since α-particle transits also kill cells, it is suggested that cell death and inflammation will also trigger carcinogenesis within tissues irradiated by these particles. Such an explanation would be consistent with the inflammation and fibrosis seen in tumor-bearing tissues irradiated by radon-222, radium-226, thorium-232, plutonium-239, and other α-emitting radionuclides. It would also provide an explanation for dose-related changes in latency and in the similar dose-responses for the same tissue in differently sized species.

12.
Environ Mol Mutagen ; 59(7): 586-594, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-30151952

RESUMEN

Existing and future nuclear fusion technologies involve the production and use of large quantities of tritium, a highly volatile, but low toxicity beta-emitting isotope of hydrogen. Tritium has received international attention because of public and scientific concerns over its release to the environment and the potential health impact of its internalization. This article provides a brief summary of the current state of knowledge of both the biological and regulatory aspects of tritium exposure; it also explores the gaps in this knowledge and provides recommendations on the best ways forward for improving our understanding of the health effects of low-level exposure to it. Linking health effects specifically to tritium exposure is challenging in epidemiological studies due to high uncertainty in tritium dosimetry and often suboptimal cohort sizes. We therefore argued that limits for tritium in drinking water should be based on evidence derived from controlled in vivo animal tritium toxicity studies that use realistically low levels of tritium. This article presents one such mouse study, undertaken within an international collaboration, and discusses the implications of its main findings, such as the similarity of the biokinetics of tritiated water (HTO) and organically bound tritium (OBT) and the higher biological effectiveness of OBT. This discussion is consistent with the position expressed in this article that in vivo animal tritium toxicity studies carried out within large, multi-partner collaborations allow evaluation of a great variety of health-related endpoints and essential to the development of international consensus on the regulation of tritium levels in the environment. Environ. Mol. Mutagen. 59:586-594, 2018. © 2018 The Authors Environmental and Molecular Mutagenesis published by Wiley Periodicals, Inc. on behalf of Environmental Mutagen Society.


Asunto(s)
Agua Potable/efectos adversos , Tritio/efectos adversos , Aminoácidos/análisis , Aminoácidos/farmacocinética , Animales , Sitios de Unión , Consenso , Agua Potable/análisis , Rayos gamma/efectos adversos , Dosimetría in Vivo , Masculino , Ratones , Ratones Endogámicos C57BL , Modelos Animales , Monitoreo de Radiación , Riesgo , Distribución Tisular , Tritio/análisis , Tritio/farmacocinética , Tritio/toxicidad , Organización Mundial de la Salud
13.
Health Phys ; 112(5): 439-444, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28350697

RESUMEN

The objective of this study was to compare the biokinetics of injected H-labeled light (HTO) and heavy (DTO) water in CBA/CaJ mice and to compare the organ distribution and/or body content of H administered by chronic ingestion for 1 mo to C57Bl/6J mice, as either H-labeled water or H-labeled amino acids (glycine, alanine and proline). HTO and DTO were administered to CBA/CaJ mice by single intraperitoneal injection and body retention was determined for up to 384 h post-injection. Tritium-labeled water or H-labeled amino acids were given to C57Bl/6J mice ad libitum for 30 d in drinking water. Body content and organ distribution of H during the period of administration and subsequent to administration was determined by liquid scintillation counting. No differences were found between the biokinetics of HTO and DTO, indicating that data generated using HTO can be used to help assess the consequences of H releases from heavy water reactors. The results for H-water showed that the concentration of radionuclide in the mice reached a peak after about 10 d and dropped rapidly after the cessation of H administration. The maximum concentration reached was only 50% of that in the water consumed, indicating that mice receive a significant fraction of their water from respiration. Contrary to the findings of others, the pattern of H retention following the administration of a cocktail of the labeled amino acids was very little different from that found for the water. This is consistent with the suggestion that most of the ingested amino acids were rapidly metabolized, releasing water and carbon dioxide.


Asunto(s)
Aminoácidos/farmacocinética , Óxido de Deuterio/farmacocinética , Deuterio/farmacocinética , Agua Potable/metabolismo , Marcaje Isotópico/métodos , Tritio/farmacocinética , Administración Oral , Aminoácidos/administración & dosificación , Aminoácidos/química , Animales , Deuterio/administración & dosificación , Deuterio/química , Óxido de Deuterio/administración & dosificación , Óxido de Deuterio/química , Femenino , Inyecciones Intravenosas , Tasa de Depuración Metabólica , Ratones , Ratones Endogámicos CBA , Especificidad de Órganos/fisiología , Distribución Tisular , Tritio/administración & dosificación , Tritio/química
14.
Radiat Res ; 186(6): 539-548, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27922333

RESUMEN

The toxicity of tritium is a public health concern given its presence and mobility in the environment. For risk predictions using radiological protection models, it is essential to allocate an appropriate radiation weighting factor (WR). This in turn should be consistent with the observed relative biological effectiveness (RBE) of tritium beta radiation. Although the International Commission on Radiological Protection (ICRP) currently recommends a WR of 1 for the calculation of committed effective dose for X rays, gamma rays and electrons of all energies, including tritium energies, there are concerns that tritium health risks are underestimated and that current regulatory tritium drinking water standards need revision. In this study, we investigated potential cytotoxic and genotoxic effects in mouse spleen after one month and eight months of chronic exposure to low-dose tritiated water (HTO). The dose regimes studied were designed to mimic human chronic consumption of HTO at levels of 10 kBq/l, 1 MBq/l and 20 MBq/l. The total doses from these radiation exposures ranged from 0.01 to 180 mGy. We also compared the biological effects of exposure to HTO with equivalent exposure to external whole-body 60Co gamma rays. Changes in spleen weight and somatic intrachromosomal recombination (DNA inversions) in spleen tissue of pKZ1Tg/+ mice were monitored. Our results showed no overall changes in either spleen organ weights and no increase mouse splenic intrachromosomal recombination frequencies, indicating that current drinking water standards for tritium exposure in the form of HTO are likely to be adequately protective against cytotoxic and genotoxic damage in spleen. These results demonstrate no evidence for cytotoxicity or genotoxicity in mouse spleen following chronic exposures to HTO activities (or equivalent gamma doses) up to 20 MBq/L.


Asunto(s)
Cromosomas de los Mamíferos/genética , Cromosomas de los Mamíferos/efectos de la radiación , Ambiente , Rayos gamma/efectos adversos , Recombinación Genética/efectos de la radiación , Bazo/metabolismo , Tritio/efectos adversos , Animales , Relación Dosis-Respuesta en la Radiación , Ratones , Ratones Endogámicos C57BL , Radiometría , Bazo/efectos de la radiación
16.
J Nucl Med ; 57(11): 1784-1791, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27307347

RESUMEN

Low-dose radiation in apolipoprotein E-deficient (ApoE-/-) mice has a protective effect with less subsequent atherosclerosis. Inflammation and apoptosis play major roles in the development of atherosclerosis. We evaluated the temporal pattern of the development of histologic atherosclerosis, inflammation with 18F-FDG, and apoptosis with 99mTc-rhAnnexin V-128 at 3 time points. METHODS: ApoE-/- mice were fed a high-fat diet, exposed to low-dose 60Co γ-radiation of 25 mGy at 2 mo of age, and evaluated within 1 wk (2-mo group), 1 mo (3-mo group), and 2 mo (4-mo group) from the time of radiation. Mice were divided into 3 subgroups and each received 18F-FDG, 99mTc-rhAnnexin V-128, or no radiotracer for autoradiography. Mice underwent euthanasia and aortic root dissection. The extent of atherosclerosis was determined by en face and Oil red O imaging. Aortic arch inflammation (18F-FDG) and apoptosis (99mTc-rhAnnexin V-128) were determined with digital autoradiography. Aortic sinus sections were stained with Sudan IV for assessment of lesion area and stage, antiCD68 antibody for inflammation and anti-cleaved-caspase 3 antibody for apoptosis. RESULTS: The extent of aortic atherosclerosis increased from 2 to 3 mo and from 3 to 4 mo. Inflammation (CD68) decreased and apoptosis (anti-cleaved-caspase 3 antibody) increased in aortic sinus slices measured as percentage of lesion by 4 mo. With increasing lesion stage, lesion inflammation decreased and lesion apoptosis increased. Aortic arch inflammation (18F-FDG uptake) did not differ over time and did not correlate with average lesion stage. However, aortic arch apoptosis (99mTc-rhAnnexin V-128) increased significantly by 4 mo and correlated with average lesion stage. There were no differences between the treatment subgroups (18F-FDG, 99mTc-rhAnnexin V-128, or no radiotracer). CONCLUSION: The temporal pattern of development of inflammation and apoptosis differ during the development of atherosclerosis in ApoE-/- mice treated with low-dose radiation. Advanced lesions are characterized by increased apoptosis and either less or similar amounts of inflammation, shown on immunohistochemistry and autoradiography. Treatment with radiotracers had no significant effects on extent of atherosclerosis, inflammation, or apoptosis.


Asunto(s)
Anexina A5 , Apoptosis/efectos de la radiación , Aterosclerosis/diagnóstico por imagen , Aterosclerosis/etiología , Compuestos de Organotecnecio , Vasculitis/diagnóstico por imagen , Vasculitis/etiología , Irradiación Corporal Total/efectos adversos , Animales , Apolipoproteínas E/genética , Aterosclerosis/patología , Relación Dosis-Respuesta en la Radiación , Femenino , Fluorodesoxiglucosa F18 , Ratones , Ratones Noqueados , Radiofármacos , Vasculitis/patología
17.
J Alzheimers Dis ; 53(3): 933-42, 2016 06 18.
Artículo en Inglés | MEDLINE | ID: mdl-27340850

RESUMEN

Aluminum, being the most abundant metal in the earth's crust, is widely distributed in the environment, and is routinely taken up by the human body through ingestion and inhalation. Aluminum is not considered an essential element and it can be toxic in high concentrations. Most of the body burden of aluminum is stored in the bones. Aluminum has been postulated to be involved in the causality of Alzheimer's disease. A system for non-invasive measurement of bone aluminum using the in vivo neutron activation analysis technique has been developed and previously reported in the literature by our group. The results are reported as ratio of Al to Ca in order to eliminate the variations in beam parameters and geometry as well as the physical variations among the subjects such as size of the hand and bone structure. This pilot study included 30 subjects, 15 diagnosed with Alzheimer's disease in mild and moderate stages and 15 control subjects, all of whom were 60 years of age or older. The mean value of aluminum for the control group was 2.7±8.2µg Al/g Ca (inverse-variance weighted mean 3.5±0.9µg Al/g Ca) and for the Alzheimer's disease subjects was 12.5±13.1µg Al/g Ca (inverse-variance weighted mean 7.6±0.6µg Al/g Ca). The difference between the mean of the Alzheimer's disease group and the mean of the control group was 9.8±15.9µg Al/g Ca, with a p-value of 0.02. An age-dependent linear increase in bone aluminum concentration was observed for all subjects. The difference in serum aluminum levels between the two groups did not reach significance.


Asunto(s)
Aluminio/análisis , Enfermedad de Alzheimer/patología , Huesos/química , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis de Activación de Neutrones/métodos , Proyectos Piloto , Escalas de Valoración Psiquiátrica , Espectrometría gamma
18.
Am Nat ; 187(5): 658-66, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-27104997

RESUMEN

Arguments about the evolutionary modification of genetic dominance have a long history in genetics, dating back more than 100 years. Mathematical investigations have shown that modifiers of the level of dominance at the locus of interest can spread at a reasonable rate only if heterozygotes at that locus are common. One hitherto neglected scenario is that of sexually antagonistic selection, which not only is ubiquitous in sexual species but also can generate stable high frequencies of heterozygotes that would appear to facilitate the spread of such modifiers. Here we present a mathematical model that shows that sexually specific dominance modification is a potential outcome of sexually antagonistic selection. Our model predicts that loci with higher levels of sexual conflict should exhibit greater differentiation between males and females in levels of dominance and that the strength of antagonistic selection experienced by one sex should be proportional to the level of dominance modification. We show that evidence from the literature is consistent with these predictions but suggest that empiricists should be alert to the possibility of there being numerous cases of sex-specific dominance. Further, in order to determine the significance of sexual conflict in the evolution of dominance, we need improved measures of sexual conflict and better characterization of loci that modify dominance of genes with sexually antagonistic fitness effects.


Asunto(s)
Modelos Genéticos , Selección Genética , Animales , Evolución Biológica , Femenino , Masculino , Caracteres Sexuales
19.
J Anim Ecol ; 85(1): 178-86, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26332860

RESUMEN

Animals must tailor their life-history strategies to suit the prevailing conditions and respond to hazards in the environment. Animals with lethal infections are faced with a difficult choice: to allocate more resources to reproduction and suffer higher mortality or to reduce reproduction with the expectation of enhanced immunity and late-age reproduction. However, the strategies employed to mediate shifts in life-history traits are largely unknown. Here, we investigate the temperature preference of the fruit fly, Drosophila melanogaster, during infection with the fungal pathogen, Metarhizium robertsii, and the consequence of temperature preference on life-history traits. We have measured the temperature preference of fruit flies under different pathogen conditions. We conducted multiple fitness assays of the host and the pathogen under different thermal conditions. From these data, we estimated standard measures of fitness and used age-specific methodologies to test for the fitness trade-offs that are thought to underlie differences in life-history strategy. We found that fungus-infected fruit flies seek out cooler temperatures, which facilitates an adaptive shift in their life-history strategy. The colder temperatures preferred by infected animals were detrimental to the pathogen because it increased resistance to infection. But, it did not provide net benefits that were specific to infected animals, as cooler temperatures increased lifetime reproductive success and survival whether or not the animals were infected. Instead, we find that cold-seeking benefits infected animals by increasing their late-age reproductive output, at a cost to their early-age reproductive output. In contrast, naive control flies prefer warmer temperatures that optimize early-age reproductive, at a cost to reproductive output at late ages. These findings show that infected animals exhibit fundamentally different reproductive strategies than their healthy counterparts. Temperature preference can facilitate shifts in strategy, but not without inevitable trade-offs.


Asunto(s)
Drosophila melanogaster/microbiología , Drosophila melanogaster/fisiología , Metarhizium/fisiología , Animales , Conducta Apetitiva , Frío , Femenino , Longevidad , Reproducción
20.
PLoS One ; 10(3): e0119661, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25799423

RESUMEN

Epidemiological studies indicate long-term risks of ionizing radiation on the heart, even at moderate doses. In this study, we investigated the inflammatory, thrombotic and fibrotic late responses of the heart after low-dose irradiation (IR) with specific emphasize on the dose rate. Hypercholesterolemic ApoE-deficient mice were sacrificed 3 and 6 months after total body irradiation (TBI) with 0.025, 0.05, 0.1, 0.5 or 2 Gy at low (1 mGy/min) or high dose rate (150 mGy/min). The expression of inflammatory and thrombotic markers was quantified in frozen heart sections (CD31, E-selectin, thrombomodulin, ICAM-1, VCAM-1, collagen IV, Thy-1, and CD45) and in plasma samples (IL6, KC, MCP-1, TNFα, INFγ, IL-1ß, TGFß, INFγ, IL-10, sICAM-1, sE-selectin, sVCAM-1 and fibrinogen) by fluorescence analysis and ELISA. We found that even very low irradiation doses induced adaptive late responses, such as increases of capillary density and changes in collagen IV and Thy-1 levels indicating compensatory regulation. Slight decreases of ICAM-1 levels and reduction of Thy 1 expression at 0.025-0.5 Gy indicate anti-inflammatory effects, whereas at the highest dose (2 Gy) increased VCAM-1 levels on the endocardium may represent a switch to a pro-inflammatory response. Plasma samples partially confirmed this pattern, showing a decrease of proinflammatory markers (sVCAM, sICAM) at 0.025-2.0 Gy. In contrast, an enhancement of MCP-1, TNFα and fibrinogen at 0.05-2.0 Gy indicated a proinflammatory and prothrombotic systemic response. Multivariate analysis also revealed significant age-dependent increases (KC, MCP-1, fibrinogen) and decreases (sICAM, sVCAM, sE-selectin) of plasma markers. This paper represents local and systemic effects of low-dose irradiation, including also age- and dose rate-dependent responses in the ApoE-/- mouse model. These insights in the multiple inflammatory/thrombotic effects caused by low-dose irradiation might facilitate an individual evaluation and intervention of radiation related, long-term side effects but also give important implications for low dose anti-inflammatory radiotherapy.


Asunto(s)
Apolipoproteínas E/deficiencia , Biomarcadores/metabolismo , Rayos gamma/efectos adversos , Corazón/efectos de la radiación , Mediadores de Inflamación/metabolismo , Inflamación/metabolismo , Traumatismos Experimentales por Radiación/metabolismo , Animales , Radioisótopos de Cobalto/efectos adversos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta en la Radiación , Ensayo de Inmunoadsorción Enzimática , Femenino , Hipercolesterolemia/metabolismo , Hipercolesterolemia/fisiopatología , Inflamación/etiología , Inflamación/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Traumatismos Experimentales por Radiación/etiología , Traumatismos Experimentales por Radiación/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...